Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  tariquidar
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-5 of 5 for your search:
Start Over
Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 030284, 03-C-0284, NCI-03-C-0284, NCT00072202, NCT00069160
PET Imaging With Tc-94m Sestamibi to Assess Resistance to Chemotherapy
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 040177, 04-C-0177, NCT00082368
Surgery Plus Chemotherapy (Doxorubicin, Vincristine and Etoposide), Mitotane, and Tariquidar to Treat Adrenocortical Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 040011, 04-C-0011, NCT00071058
Phase I Study of XR9576 and Vinorelbine in Patients With Advanced Cancer (Summary Last Modified 09/2001)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-00-C-0044
Phase I Study of Tariquidar Combined With Docetaxel, Doxorubicin, or Vinorelbine in Children With Relapsed or Refractory Solid Tumors (Closed to Accrual as of 8/9/2009)
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 2 to 18
Sponsor: NCI
Protocol IDs: NCI-01-C-0091, NCT00020514
Start Over